Danny Welch
Danny Welch is an American cancer researcher and the Associate Director for Basic Sciences at the University of Kansas Cancer Center. He is known for his work on metastasis, the process by which cancer spreads from one part of the body to another.
Early life and education[edit | edit source]
Welch was born and raised in the United States. He completed his undergraduate studies in biology at the University of California, Los Angeles (UCLA). He then went on to earn his Ph.D. in biochemistry from the University of California, San Francisco (UCSF).
Career[edit | edit source]
After completing his education, Welch joined the faculty at the University of Alabama at Birmingham (UAB), where he began his research on metastasis. His work at UAB led to the discovery of the first metastasis suppressor genes, which are genes that can prevent cancer from spreading.
In 2010, Welch moved to the University of Kansas Cancer Center, where he currently serves as the Associate Director for Basic Sciences. His research continues to focus on understanding the mechanisms of metastasis and developing potential treatments to prevent or slow the spread of cancer.
Research and contributions[edit | edit source]
Welch's research has significantly advanced our understanding of metastasis. His discovery of metastasis suppressor genes has opened up new avenues for cancer treatment and has the potential to significantly improve patient outcomes.
In addition to his research, Welch has also made significant contributions to the field of cancer research through his leadership roles in various scientific organizations and his efforts to mentor the next generation of cancer researchers.
Awards and recognition[edit | edit source]
Over the course of his career, Welch has received numerous awards and recognition for his contributions to cancer research. These include the National Cancer Institute's Outstanding Investigator Award and the American Association for Cancer Research's Award for Outstanding Achievement in Cancer Research.
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD